Kamil Sklodowski
About Kamil Sklodowski
Kamil Sklodowski is a Study Director at Celerion in Lincoln, Nebraska, with a strong background in Life Sciences and Project Management. He has extensive experience in the pharmaceutical industry, including previous roles at Eth Zurich and the Max Planck Institute.
Work at Celerion
Kamil Sklodowski has been serving as a Study Director at Celerion since 2017. In this role, he oversees clinical studies and ensures compliance with regulatory standards. His responsibilities include managing study protocols, coordinating with cross-functional teams, and analyzing data to support pharmaceutical research. Prior to his current position, he worked as a Staff Technical Writer at Celerion for five months in 2016, where he developed technical documentation and contributed to project communication.
Education and Expertise
Kamil Sklodowski holds a Doctorate in Philosophy from the Max Planck Society, where he studied Biology, Physiology, and Biochemistry from 2010 to 2015. He earned a Master's degree from the University of Bayreuth from 2008 to 2010. Additionally, he completed his Bachelor's degree at Uniwersytet Śląski W Katowicach from 2005 to 2008. He has also studied at Zhaw Zurich University of Applied Sciences. His educational background provides a strong foundation in Life Sciences and Project Management.
Background
Before joining Celerion, Kamil Sklodowski worked as a PhD Candidate at the Max Planck Institute of Molecular Plant Physiology from 2010 to 2015. He also held a postdoctoral position at ETH Zurich for 11 months in 2015 to 2016. His diverse experiences in academic and research settings have contributed to his expertise in the pharmaceutical industry.
Achievements
Kamil Sklodowski possesses strong computer skills, particularly in data analysis, presentation, and scientific writing. He has hands-on experience with various analytical lab techniques, which enhances his effectiveness as a Study Director. His ability to communicate fluently in three languages supports his work in the international pharmaceutical sector, facilitating collaboration and knowledge exchange.